enVVeno Medical Corporation - Common Stock — Quarterly Cash Flow (NASDAQ:NVNO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 40.58 M36.58 M32.35 M29.56 M26.1 M Total liabilities 2.27 M3.52 M2.9 M2.43 M2.35 M Total equity 38.31 M33.06 M29.45 M27.13 M23.75 M Total liabilities & shareholders' equities 40.58 M36.58 M32.35 M29.56 M26.1 M Total debt ————— Net debt —————

News

enVVeno Medical regains Nasdaq compliance, reports $28 million cash

enVVeno Medical announces 1-for-35 reverse stock split

enVVeno Medical updates bylaws to revise stockholder quorum requirement

enVVeno Medical stock plunges after FDA upholds rejection of VenoValve

Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher - Amaze Holdings (AMEX:AMZE), Cidara Therapeutics (NASDAQ:CDTX)

Nasdaq Dips Over 300 Points; Applied Materials Posts Upbeat Q4 Earnings - Applied Mat (NASDAQ:AMAT), Amaze Holdings (AMEX:AMZE)

Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Binah Capital Group (NASDAQ:BCG), Aspire Biopharma Hldgs (NASDAQ:ASBP)

FDA rejects enVVeno Medical’s appeal for VenoValve approval

EnVVeno Medical receives Nasdaq notice for minimum bid price non-compliance

enVVeno Medical to appeal FDA’s not-approvable letter for VenoValve

NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve

Nasdaq Down 1%; Lowe's Posts Upbeat Earnings - Calidi Biotherapeutics (AMEX:CLDI), Guess (NYSE:GES)